Discovery of extracellular RNA biomarkers from human blood serum and plasma

Extracellular RNA (exRNA) sequencing from human liquid biopsy has exhibited the potential for development of future disease diagnosis. Multiple rotation openings are created to characterize the fundamental properties of exRNA based on exRNA sequencing data and discover exRNA biomarkers for Alzheimer's disease and cancer.